Clinical Trial Update: Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections [Phase 2]

View source ↗

Summary

Phase 2 trial comparing TP-434 with ertapenem for complicated intra-abdominal infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• ERTAPENEM (ertapenem)
• TP-434

Snippet

Sponsor: Tetraphase Pharmaceuticals, Inc | Conditions: Complicated Intra-abdominal Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-09-04